Last Updated: August 4, 2026

Claims for Patent: 10,799,563

✉ Email this page to a colleague

Summary for Patent: 10,799,563

Title:	Polymeric hGH prodrugs
Abstract:	The present invention relates to a polymeric human growth hormone prodrug and dry, liquid and reconstituted pharmaceutical formulations comprising said prodrug. It furthermore relates to their use as medicaments for the treatment of diseases which can be treated with growth hormone and to methods of treatment. It also relates to methods of application of such polymeric human growth hormone prodrug or pharmaceutical formulation.
Inventor(s):	Kurpiers Thomas, Rau Harald, Exner Evelyn, Jensen Steen, Rasmussen Grethe Nørskov, Lessmann Torben, Wegge Thomas, Hermann Alina, Schubert Nina, Splanemann Anna, Zettler Joachim
Assignee:	Ascendis Pharma Endocrinology Division
Application Number:	US15527744
Patent Claims:

Details for Patent 10,799,563

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ascendis Pharma Endocrinology Division A/s	SKYTROFA	lonapegsomatropin-tcgd	For Injection	761177	August 25, 2021	10,799,563	2035-11-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,799,563

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016079114	⤷ Start Trial
United States of America	12133883	⤷ Start Trial
United States of America	2017354716	⤷ Start Trial
United States of America	2020390864	⤷ Start Trial
United States of America	2025032587	⤷ Start Trial
San Marino	T202100172	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.